Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.42
Bid: 8.20
Ask: 8.40
Change: 0.00 (0.00%)
Spread: 0.20 (2.439%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.42
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Fundraise

11 Nov 2019 07:00

RNS Number : 8863S
Agronomics Limited
11 November 2019
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. PLEASE SEE THE SECTION ENTITLED "IMPORTANT NOTE" TOWARDS THE END OF THIS ANNOUNCEMENT.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ('MAR). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

11 November 2019

Agronomics Ltd

("Agronomics" or the "Company")

Response to Press Speculation regarding a Proposed Fundraise of up to £20 million

Appointment of Zeus Capital as Joint Broker

In response to press speculation over the weekend, the Company confirms that it is putting in place plans to raise up to £20 million through an issue of new Ordinary Shares, further details of which are set out below.

Background to the Proposed Fundraise

On 29 October 2019, Agronomics announced that it had made an investment in Shiok Meats, on 17 October 2019, Agronomics announced that it had made a further investment in Vitrolabs Inc, and on 15 October 2019, it announced an investment into Rebellyous Foods. Given the scale of the opportunity to invest in the nascent "cultivated meat" and related sectors, and the resources available after the completion of recent investments, the Company's board has approved in principle a proposed equity raise to finance its growing pipeline of opportunities. The Company proposes to target a raise of up to £20 million through an issue of new Ordinary Shares (the "Fundraise").

The Company's intention is to price the new shares offered pursuant to the Fundraise at the unaudited net asset value per share of the Company's portfolio at 30 September 2019, being 5.5p. The Board reserves the right to increase or decrease the size of the Fundraise or alter the proposed price at which new shares are offered, depending on demand and the strategic value to the Company of proposed investors. The Fundraise is expected to close by 29 November 2019 at which time a further announcement will be made.

The Company has appointed Zeus Capital Limited ("Zeus Capital") to act as its broker to assist with the Fundraise.

Appointment of Joint- Broker

Prior to launching the roadshow for the proposed placing, the Company is pleased to announce the appointment of Zeus Capital Limited as the Company's co-broker with immediate effect.

The Placing

The Placing will take place through the Company's Joint Brokers, Zeus Capital and Peterhouse Corporate Finance. This Placing will take place after a roadshow being arranged by Zeus Capital. The final number and pricing of new Ordinary Shares will be agreed between the Company and Zeus Capital following close of the Placing and announced shortly thereafter. Details of the Placing will be announced upon completion of the roadshow. Parties interested in participating in the Fundraise should contact Zeus Capital at the contact details below.

Nothing in this announcement comprises an offer to any person to subscribe for any Ordinary Shares.

Directors' Participation

Jim Mellon, a Non-Executive Director, has indicated to the Board his willingness to participate in the Proposed Fundraise in an amount of up to £2 million (subject to his shareholding and that of any parties of which he is deemed as being in concert remaining below 30%). It is expected that Richard Reed, Non-Executive Chairman will also participate in the Fundraise. To the extent that such participations are Related Party Transactions under the AIM Rules for Companies, the requirements of the AIM Rules will be dealt with at the time that the terms of the fundraise are announced.

Termination of Optiva as Broker

Concurrent with the appointment of Zeus as Joint Broker (effective today) the appointment of Optiva Securities Limited as broker to the Company has been terminated.

 

For further information, please contact:

 

Agronomics Limited

Beaumont Cornish Limited

 

Zeus Capital

Peterhouse Corporate Finance

The Company

 

Nomad

Joint Broker

Joint Broker

Richard Reed

Denham Eke

 

Roland Cornish

James Biddle

 

Mike Seabrook

Rupert Woolfenden

 

Lucy Williams

 

+44 (0) 1624 639396

+44 (0) 207 628 3396

+44 (0) 20 3829 5000

+44 (0) 207 469 0936

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGMMMMZGMGLZZ
Date   Source Headline
12th Oct 20167:00 amRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSNet Asset Value(s)
29th Apr 20167:00 amRNSNet Asset Value calculation to 31 March 2016
15th Apr 20167:00 amRNSChange of Adviser
18th Mar 20167:00 amRNSHolding(s) in Company
17th Mar 20167:00 amRNSInterim Results for the six months to 31 Dec 2015
10th Feb 201612:11 pmRNSResult of AGM
25th Jan 20167:00 amRNSNet Asset Value(s)
22nd Dec 20157:00 amRNSAnnual Audited Results and Notice of AGM
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
4th Nov 20157:00 amRNSNet Asset Value(s)
30th Jul 20157:01 amRNSNet Asset Value(s)
15th Apr 20157:00 amRNSNet Asset Value as at 31 March 2015
30th Mar 20157:00 amRNSInterim results for 6 months to 31 December 2014
6th Feb 201512:21 pmRNSClose of Tender Offer
4th Feb 20155:36 pmRNSRe Results of Tender Offer
2nd Feb 20158:00 amRNSResults of Tender Offer
23rd Jan 20157:00 amRNSHolding(s) in Company
15th Jan 201511:56 amRNSHolding(s) in Company
14th Jan 20157:00 amRNSTender Offer
12th Jan 20159:32 amRNSNet Asset Value
30th Dec 20147:00 amRNSAnnual audited results
23rd Dec 201411:58 amRNSHolding(s) in Company
28th Nov 20142:04 pmRNSTender Offer in respect of Magna Biopharma
21st Oct 20147:00 amRNSNet Asset Value to 30 September 2014
22nd Jul 20147:00 amRNSNet Asset Value(s)
8th Apr 20147:00 amRNSNet Asset Value calculations to 31 March 2014
31st Mar 20147:00 amRNSInterim Results for the six months to 31 Dec 2013
24th Jan 201411:21 amRNSHolding(s) in Company
20th Jan 201410:56 amRNSHolding(s) in Company
17th Jan 20147:00 amRNSNet Asset Value(s)
15th Jan 20147:00 amRNSAppointment of Nominated Adviser
6th Jan 20145:49 pmRNSHolding(s) in Company
20th Nov 20134:04 pmRNSHolding(s) in Company
13th Nov 20135:13 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSResult of General Meeting
24th Oct 20137:01 amRNSNotice of General Meeting
24th Oct 20137:00 amRNSAnnual Financial Report
18th Oct 201311:23 amRNSHolding(s) in Company
18th Oct 20137:00 amRNSNet Asset Value(s)
4th Oct 20132:13 pmRNSHolding(s) in Company
26th Sep 20135:10 pmRNSHolding(s) in Company
13th Sep 201311:32 amRNSHolding(s) in Company
6th Sep 20135:29 pmRNSHolding(s) in Company
6th Aug 20139:40 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSNet Asset Value(s)
15th Apr 201312:34 pmRNSDirectorate Change
12th Apr 20132:17 pmRNSHolding(s) in Company
10th Apr 20137:00 amRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSNet Asset Value calculation to 31st March 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.